1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Emerging Trends in Neuromodulators (Technical Insights)

Emerging Trends in Neuromodulators (Technical Insights)

  • September 2014
  • -
  • Frost & Sullivan
  • -
  • 68 pages

Exciting Technological and Business Vistas on the Horizon

This research service showcases existing, emerging and cutting-edge Neuromodulation technologies. The report studies the role of Neuromodulation in pain management, treatment of neurological, psychiatric, behavioural and other nervous system disorders; and maps changing trends from invasive to non-invasive technologies and the convergence of different technologies to create hybrid Neuromodulation systems. We also capture recent funding deals and emerging business opportunities, to indicate the industry’s appetite for growth. Based on the observed industry best practices, key market forces and user needs, we provide strategic recommendations on funding, partnerships and stakeholder engagement.

Scope of Research

Key Focus Areas
-Technology trends: This reports highlights technological advances that are enabling next-generation Neuromodulation devices. Innovations in core technologies, incremental product enhancements and convergence of different technologies are assessed.
-Market forces: Market accelerators and challenges and their impact on technology and business prospects. The report maps the influence and impact of these market forces over short and long terms and 5-year outlook for the Neuromodulation industry.
-Funding and business opportunities: The report assesses the general attitude of government and private funding in this space, recent deals made across the globe and some strategies companies can employ to maximise business opportunities and better engage stakeholders.
-This research service (RS) will showcase emerging neuromodulation technologies and throw light on certain key technical and business factors, such as technology capability, maturity of technology, global research intensity and adoption, funding and patent activities.
-Based on our survey and observation of the neuromodulation industry, we clustered technologies into three categories existing, emerging and cutting-edge, based on technology maturity and extent of adoption. Accordingly, these technology clusters represent the technology roadmap.
-The market scope of this report is global – we approached this industry from a technology point of view and consequently, we provided information about different technologies and their reach in different regions.
-The report studies the role of Neuromodulation in pain management, treatment of neurological, psychiatric, behavioural and other nervous system disorders; and maps changing trends from invasive to non-invasive technologies and the convergence of different technologies to create hybrid Neuromodulation systems.
-Based on the observed industry best practices, key market forces and user needs, we provide strategic recommendations on funding, partnerships and stakeholder engagement.

Table Of Contents

Emerging Trends in Neuromodulators (Technical Insights)
1. EXECUTIVE SUMMARY

Executive Summary
Scope of Research
Research Methodology
Key Findings

2. TECHNOLOGY SNAPSHOT AND TRENDS

Technology Snapshot and Trends
Introduction to Neuromodulation
Technology Snapshot
Assessment of Technology Maturity
Neuromodulation Applications

3. IMPACT ASSESSMENT AND ANALYSIS

Impact Assessment and Analysis
Key Market Drivers
Key Market Challenges
Neuromodulator Stakeholder Network
Assessment of Regional Adoption

4. OPPORTUNITY EVALUATION AND ROADMAPPING

Opportunity Evaluation and Roadmapping
Assessment of Government Funding
Assessment of Private Funding
Assessment of Other Funding Sources
Industry Roadmap
Assessment of Emerging Opportunities
Conclusion

5. KEY PATENTS, DECISION SUPPORT DATABASE and INDUSTRY PARTICIPANT CONTACTS

Key Patents, Decision Support Database and Industry Participant Contacts
Recent IP Activity -
Decision Support Database
List of Key Industry Participants
Legal Disclaimer

6. THE FROST and SULLIVAN STORY

The Frost and Sullivan Story
Who is Frost and Sullivan
What Makes Us Unique
TEAM Methodology
Our Global Footprint 40+ Offices

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

Opioid Market in Iran

  • December 2016
    8 pages
  • Opioid  

  • Iran  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.